UBS upgraded Revvity (LSE:0KHE) from Neutral to Buy on May 1, 2025, with a one-year price target averaging 131.72 GBX/share, indicating a potential 42.31% upside from its last closing price of 92.56 GBX/share. Institutional ownership has increased, with 1,078 funds reporting positions, and total shares owned rising by 3.77% to 136,158K shares. Notable shareholders include T. Rowe Price Investment Management, which increased its stake by 14.30% to 20,761K shares.